Biogen (BIIB) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $196.58 -1.05%
Revenue Growth %: -6.5%
Financial Fact:
Other: 98.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -6.5%
Financial Fact:
Other: 98.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Reiterates Buy Rating on Biogen (BIIB)
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Vail Resorts taps bankers for potential activist defense, Semafor reports
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
